Connected health tools, including mobile phones, incorporate various functions that capture events, direct actions, and make informed decisions based on complex sources of data. Connected health, a term recently proposed by some academics and industry, refers to the development, testing, and integration of smart technology tools into health care. Through these means, connected health creates interconnectivity across various environments, profoundly changing the way we learn, self-regulate, and communicate with one another. In health care, mobile phones enable more precise diagnostics, personalized health recommendations that enhance patient experiences and outcomes while containing health care costs. However, for connected health to achieve its full potential, issues must be addressed pertaining to active engagement in use, privacy, security, and quality, as well as the development of evidence-based guidelines. This commentary discusses these key challenges and explores the promise of connected health, specifically eHealth and mHealth. Anchored within the context of cancer, the authors’ area of expertise, the ideas put forward can readily be applied to other health-related disciplines.

No abstract

No abstract

No abstract

The  Purpose  of  this  study  was  to  examine  the  lipid  lowering  activity  of  aqueous:  ethanol  (1:1)  extract  of Carissa  carandas  in  Egg  yolk  induced  hyperlipidemic  rats.  A  highly  significant  increase  in  the  weight  of  group C (High cholesterol  diet)  rats  was  observed  when  compared  with  control  group N (P<0.01).  The  extract  caused  a  significant reduction  in  body  weight,  Cholesterol,  Triglycerides,  HDL  and  LDL  in  hyperlipidemic  rats.  Histopathological  changes induced by  high cholesterol diet were  also significantly reduced by the  extract. The  activity of  ethanol  and water extract of C. carandas was comparable to that of atorvastatin.